Mission statement · Company scope
“Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing and acquiring novel rare disease products.”
In use2021 – now1 sighting
First seenJan 2021Added
Last seenJan 2021Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Market leadership (primary) · Innovation
- Leads with
- Rank
- Best for
- Climate & health
- Formula
- The [rank] [category] for [who]
- Tone
- Plain
- Length
- 23 words · reading grade 14.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_de68187dd9582831
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2021-01-14 · sec_sentence · 424B4 · accession 0001140361-21-001146
View filing ↗0 to compareCompare